CHICAGO (Reuters) - U.S. researchers are targeting a deadly brain cancer by taking aim at a common virus active in most people with these tumors.
The hope is to trick the immune system into attacking the cancer. So far, it seems to be helping, researchers at Duke University in North Carolina said on Monday.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
